Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
117,557,908
-
Total 13F shares
-
70,505,001
-
Share change
-
+4,294,484
-
Total reported value
-
$12,760,866,584
-
Put/Call ratio
-
139%
-
Price per share
-
$181.00
-
Number of holders
-
310
-
Value change
-
+$832,242,795
-
Number of buys
-
192
-
Number of sells
-
143
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q1 2021
As of 31 Mar 2021,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
310 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,505,001 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., MORGAN STANLEY, ARK Investment Management LLC, Foresite Capital Management II, LLC, Meritech Capital Associates V L.L.C., 12 West Capital Management LP, AMERIPRISE FINANCIAL INC, and BAILLIE GIFFORD & CO.
This page lists
310
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.